1. Geissler HJ, Mehlhorn U. Cold crystalloid cardioplegia. MMCTS. 2004;001040:1-4.
2. Custodiol® HTK Solution; The multi-organ solution: preservation and protection in organ transplantation.
3. Tang Q and He G-W. Effect of cardioplegic and organ preservation solutions and their components on coronary endothelium-derived relaxing factors. Ann Thorac Surg. 2005;80:757.el-757.e13
4. Careaga G, Salazar D, Tellez S, Sanchez O, Borrayo G, Argulero R, Clinical impact of histidine-ketoglutarate-tryptophan (HTK) cardioplegic solution on the perioperative period in open heart surgery subjects. Arch Med Red. 2001:32:296-299.
5. Hachida M, Ookado A, Nonoyama M, Koyanagi H. Effect of HTK Solution for myocardial preservation. J Cardiovasc Surg. 1996;37:269-274.
6. Preusse CJ. Optimization of Myocardial Protection. In: Heiss EW, editor. Advances in clinical cardiology. New York: G. Witzstrock; 1980:581-591.
7. CUSTODIOL® [package insert]. Ewing, NJ: Essential Pharmaceuticals, LLC; 2009.